UNSPSC 51384522: Dexketoprofen trometamol

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14O3.C4H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N674F7L21E, chemically known as benzeneacetic acid, 3-benzoyl-.alpha.-methyl-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1), (.alpha.s)-, but more generally known as dexketoprofen trometamol, which bears US NIH Compound Identifier 177976.

European Medicines Agency schedules dexketoprofen trometamol or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07034MIG. Most nations, for tariff purposes, schedule dexketoprofen trometamol under HS 29183000. SMILES: C[C@@H](C1CCCC(C1)C(=O)C2CCCCC2)C(=O)O.C(C(CO)(CO)N)O.

UNSPSC 51384522 Dexketoprofen trometamol is a Commodity code that in practice captures emergency medical and pharmaceutical procurement by state and local health and safety agencies, though recent solicitation activity under this code shows limited alignment with the nominal pharmaceutical scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—procures naloxone and drug deactivation systems rather than dexketoprofen trometamol itself, suggesting either a tagging mismatch or a broader interpretation of the code to encompass emergency-response pharmaceuticals and medical countermeasures. Issuing bodies using this code include county health departments and community health programs focused on overdose response and substance-use intervention; the Seminole County example reflects public health procurement tied to opioid crisis mitigation rather than commercial pharmaceutical distribution.

Seminole County, Florida represents the primary geographic activity visible in recent records. The county's IFB posted June 30, 2026, with a response deadline of July 26, 2023 (an apparent date error in the source), seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Bidders must include all shipping and delivery costs, provide unit pricing for each line item, comply with drug-free workplace and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The procurement does not specify set-aside designations and may carry FEMA funding, which introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. Given the sparse recent-opportunity record under this code, activity levels appear low relative to the breadth of state and local pharmaceutical procurement.